Jiangsu Hengrui Medicine Co., Ltd.
600276.SS
$0.02
Change (1 day)
$8.10
Year High
$5.00
Year Low
Categories
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.
Stock split history for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
Jiangsu Hengrui Medicine Co., Ltd. stock (symbol: 600276.SS) underwent a total of 19 stock splits.
The most recent stock split occured on Jun 10, 2021.
Annual Revenue
| Date | Splite | Multiple |
|---|---|---|
| 2021-06-10 | 1.2:1 | 1.2 |
| 2020-05-25 | 1.2:1 | 1.2 |
| 2019-03-28 | 1.2:1 | 1.2 |
| 2018-05-30 | 1.3:1 | 1.3 |
| 2017-05-31 | 12:10 | 12 |
| 2016-06-16 | 12:10 | 12 |
| 2015-06-15 | 13:10 | 13 |
| 2014-05-15 | 11:10 | 11 |
| 2013-06-07 | 1.1:1 | 1.1 |
| 2012-05-29 | 11:10 | 11 |
| 2011-04-26 | 15:10 | 15 |
| 2010-03-17 | 12:10 | 12 |
| 2009-04-30 | 12:10 | 12 |
| 2008-04-11 | 12:10 | 12 |
| 2007-04-02 | 13:10 | 13 |
| 2006-08-29 | 1.3:1 | 1.3 |
| 2006-06-19 | 12:10 | 12 |
| 2002-05-21 | 12:10 | 12 |
| 2001-05-11 | 13:10 | 13 |